3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
2
Withdrawn
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
2
Conditions
Prostatic Neoplasms
35
Prostate Cancer Metastatic
3
Neoplasm Metastasis
3
Prostate CA
2
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
2
Triple Negative Breast Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Diseases
1
Oligometastatic Prostate Cancer
1
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
1
Metastatic Castration-resistant Prostate Cancer
1
Intraprostatic Prostate Cancer
1
Genital Diseases, Male
1
Breast Neoplasms
1
Adenocarcinoma
1
Interventions
darolutamide
2
Androgen Antagonists
2
relugolix
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
×
Androgen Antagonists
×
Clear all
NCT06661122
2026-05-19
HAYATE
Bayer
Recruiting
100 enrolled
NCT07216248
2025-10-29
OPTIMAS
University of Utah
Phase 2
Recruiting
160 enrolled